Sterling Investment Advisors (Pennsylvania)’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-120
| Closed | -$1K | – | 579 |
|
|
2022
Q2 | $1K | Sell |
120
-80
| -40% | -$667 | ﹤0.01% | 545 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 551 |
|
|
2021
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 526 |
|
|
2021
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 471 |
|
|
2021
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 442 |
|
|
2021
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 424 |
|
|
2020
Q4 | $12K | Buy |
200
+80
| +67% | +$4.8K | ﹤0.01% | 350 |
|
|
2020
Q3 | $16K | Hold |
120
| – | – | 0.01% | 315 |
|
|
2020
Q2 | $20K | Hold |
120
| – | – | 0.01% | 300 |
|
|
2020
Q1 | $17K | Buy |
120
+40
| +50% | +$5.67K | 0.01% | 287 |
|
|
2019
Q4 | $26K | Hold |
80
| – | – | 0.01% | 272 |
|
|
2019
Q3 | $40K | Buy |
80
+40
| +100% | +$20K | 0.02% | 228 |
|
|
2019
Q2 | $24K | Hold |
40
| – | – | 0.01% | 281 |
|
|
2019
Q1 | $24K | Hold |
40
| – | – | 0.01% | 281 |
|
|
2018
Q4 | $14K | Buy |
+40
| New | +$14K | 0.01% | 311 |
|